Motif Bio Share Discussion Threads

[pjj71] 22/12/2017 07:24

FDA approval will be granted by then and probably the first ex US farmout... this should be 100p by now...

[ohisay] 22/12/2017 07:12

The loan balance under the Facility after the Additional Draw will be US $6,187,786 including fees and accrued interest through the date of close. The loan balance will be repaid in 7 monthly instalments from 15 June - 15 December 2018. Prior to this change the loan balance would have come due on 15 January 2018.

Under the terms of the Additional Draw, the interest rate will be 10%. The Lender will also receive 10% of the appreciation on 12,000,000 ordinary shares of Motif Bio plc above 35 pence. The proceeds are to be used for working capital for Amphion and its Partner Companies.

The current loan under the Facility continues to be secured by the pledge by the Company of 36,371,625 ordinary shares of Motif Bio plc. Amphion has transferred the legal title to, but retains the beneficial interest in, the total pledged shares. The Lender has agreed not to sell any ordinary shares of Motif Bio plc until 15 June 2018 as long as the Company remains in compliance with the terms of the Facility.

[t-trader] 22/12/2017 07:09

Good news regarding AMP......will not be selling any shares until June 2018 instead of January 2018 as previously stated.

[t-trader] 22/12/2017 07:09

Double post

[longshanks] 21/12/2017 16:33

They have been unerringly consistent with their timings to date: most welcome in any investment and raises confidence that they will meet the objective of initiating sales of Iclaprim in about one years time.Terribly undervalued but happy to sit and hold as now they have had a year on NASDAQ they will be in a position next year to properly market the company potential to US fund managers.

[t-trader] 21/12/2017 16:20

It is very undervalued Tilly, it has been a very frustrating year regarding the share price. 2018 will be our year, so just a bit more patience required and true value will eventually be realized.

[tilly99] 21/12/2017 16:07

Sorry qtr1 so same timescale?This is so undervalued

[waterloo01] 21/12/2017 13:49

It's further data which continues to back the case and confirms the 1st Q filing of the NDA. Prior said anticipated would do in 1st Q (I think)

[tilly99] 21/12/2017 13:44

WaterlooWasn't this expected?

[waterloo01] 21/12/2017 13:26

Safety looks to have held well which is important as was a concern to some in the US. Interesting thing about RNS's this time of year is many traders and II's are 'off duty' so some interesting opportunities on occasion. Interesting to see Nasdaq shortly

[phowdo] 21/12/2017 13:22

News not showing on advfn.

[waterloo01] 21/12/2017 13:11

Excellent going for 1st Q filing.

[blueblood] 15/12/2017 12:17

Really? Where's that news?

[hoggar] 15/12/2017 11:59

Amp have already agreed the loan due in Jan 18 to be fully converted into Amp shares at 8p. Amp will retain their 14% stake in MTFB until a realistic share price has been achieved or a sizable takeover appears.

[blueblood] 15/12/2017 10:52

We just need AMP to get funding sorted or sell their holding here. I am sure they would find great institutional demand for their c15% holding at these levels. Looking forward to seeing where share price is at end of Jan!

[pjj71] 15/12/2017 10:40

amazing how IMM goes ever higher as this tanks ever lower...

[blueblood] 14/12/2017 12:55

Once AMP funding issue or sale is resolved mid Jan the FDA application looms large and I believe we will be 60p+ at end of Jan unless AMP are forced into dumping the lot!

[tilly99] 14/12/2017 12:04

I'd be happy with 99p!!Yes this is crazy valuation and this is now one of my biggest holdings Feels like buyers can't wait to grab AMP stake

[blueblood] 14/12/2017 09:15

IMM, PYC, VAL etc all multibaggers with only fraction of MTFBs potential especially given our P3 trial success. Scandalous we are still around were we were after listing given the progress. When's our turn to share the gains? If we aren't careful we will be taken out way under true value ie under £1!

[pyglet] 14/12/2017 09:08

Today's RNS must take the crown as the most difficult to understand ever.

[tilly99] 13/12/2017 19:33

That's where I'm a seller I have no doubt we will go a lot higher

[small crow] 13/12/2017 18:50

Your target is too modest ....

[tilly99] 13/12/2017 16:52

If Val can go up 7 fold we can double!!I had millions of Val and now I'm v big in this My tgt 70p

[blueblood] 13/12/2017 13:35

Wouldn't it make sense for big pharma to take us out now for pocket money?